Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 9—September 2007

Parenteral Transmission of the Novel Human Parvovirus PARV4

Peter Simmonds*Comments to Author , Ashleigh Manning*, Rachel Kenneil*, Frances W. Carnie†, and Jeanne E. Bell†
Author affiliations: *University of Edinburgh, Edinburgh, Scotland, United Kingdom; †Western General Hospital, Edinburgh, Scotland, United Kingdom;

Main Article

Table 2

Concordance of parvovirus B19 and PARV4 detection between bone marrow and lymphoid tissue*

Virus detected and risk group Lymphoid tissue
Positive Negative
B19 (all risk groups)
Bone marrow
Positive 27 1
Negative 3 29
PARV4 (IDUs and persons with hemophilia)
Bone marrow
Positive 14 1
Negative 2 21

*IDUs, injection drug users.

Main Article

Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.